Diagnosis and treatment of latent infection withMycobacterium tuberculosis
Open Access
- 29 October 2012
- journal article
- review article
- Published by Wiley in Respirology
- Vol. 18 (2), 205-216
- https://doi.org/10.1111/resp.12002
Abstract
In clinical practice, latent infection with Mycobacterium tuberculosis is defined by the presence of an M. tuberculosis‐specific immune response in the absence of active tuberculosis. Targeted testing of individuals from risk groups with the tuberculin skin test or an interferon‐γ release assay is currently the best method to identify those with the highest risk for progression to tuberculosis. Positive predictive values of the immunodiagnostic tests are substantially influenced by the type of test, the age of the person who is tested, the prevalence of tuberculosis in the society and the risk group to which the person belongs. As a general rule, testing should only be offered when preventive chemotherapy will be accepted in the case of a positive test result. Preventive chemotherapy can effectively protect individuals at risk from the development of tuberculosis, although at least 3 months of combination therapy or up to 9 months of monotherapy are required, and overall acceptance rate is low. Improvements of the current generation of immunodiagnostic tests could substantially lower the number of individuals that need to be treated to prevent a case of tuberculosis. If shorter treatment regimens were equally effective than those currently recommended, acceptance of preventive chemotherapy could be much improved.Keywords
This publication has 89 references indexed in Scilit:
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2011
- Tuberculosis contact investigation in low prevalence countries: a European consensusEuropean Respiratory Journal, 2010
- Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypesNature Reviews Microbiology, 2010
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategiesNature Reviews Microbiology, 2009
- Factors that deregulate the protective immune response in tuberculosisArchivum Immunologiae et Therapiae Experimentalis, 2009
- Eliminating latent tuberculosisTrends in Microbiology, 2009
- LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementEuropean Respiratory Journal, 2009
- Impaired Expression of Perforin and Granulysin in CD8+T Cells at the Site of Infection in Human Chronic Pulmonary TuberculosisInfection and Immunity, 2007
- Tuberculosis: a problem with persistenceNature Reviews Microbiology, 2003
- THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCEAmerican Journal of Epidemiology, 1974